Stocks

Goldman Sachs 1Q EPS $11.58 vs. $8.79 YoY, but Undershoots its Revenue Target

 Stocks

Goldman Sachs (GS) tonight, on April 15, 2023, reported Q1 earnings, exceeding analysts' expectations for earnings per share (EPS) but missing in terms of its revenue.

April 15, 2024

views 2547
Google Reported Very Upbeat Quarterly Numbers, with Particularly Strong YouTube Economic and even Google Cloud Catching Up!

Google Reported Very Upbeat Quarterly Numbers, with Particularly Strong YouTube Economic and even Google Cloud Catching Up!

Google (GOOGL) reported its Q4 earnings, with revenue and EPS beating expectations.

January 31, 2024

views 1126
Tyson Foods Posted Sharply Lower Quarterly Results, Shares Dropping Fast

Tyson Foods Posted Sharply Lower Quarterly Results, Shares Dropping Fast

Shares of Tyson Foods (TSN), one of the world’s largest food companies and a leader in protein supplements with leading brands

November 13, 2023

views 1167
Ryanair Sales Hit €8.6 Billion, Operating Revenue Up 30 Percent, but Management Skeptical about Keeping Similar Pace Going Forward

Ryanair Sales Hit €8.6 Billion, Operating Revenue Up 30 Percent, but Management Skeptical about Keeping Similar Pace Going Forward

Ryanair Holdings (RYAAY) just released its quarterly earnings report showing that revenue in 1H of fiscal 2023 rose to €8.6 Billion, posting an annual increase of 30%.

November 6, 2023

views 1134

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2755
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2652
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2643
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2591
Stocks

Goldman Sachs 1Q EPS $11.58 vs. $8.79 YoY, but Undershoots its Revenue Target

April 15, 2024

views 2547
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.